Cannabis Law Report

JUNE 26, 2019

“The purpose of this Programme is to facilitate compassionate access to cannabis for medical reasons, where conventional treatment has failed. Authorisation will be on a named-patient arrangement and subject to the following conditions: Treatment is consultant-initiated. Online reimbursement approval is required for each patient.

Medicine 55

Medicine Access Business Legislation 55

Veriheal

OCTOBER 5, 2020

The qualifying conditions for medical cannabis has been established in the bill as follows: Amyotrophic Lateral Sclerosis (ALS), Cachexia, Cancer, Chronic Pain, Crohn’s Disease, Epilepsy, Glaucoma, HIV/Aids, Lupus, Multiple Sclerosis, Nausea, Persistent Muscle Spasms, Post-traumatic Stress Disorder (PTSD), Rheumatoid Arthritis. .

Edibles 52

Edibles Legalization Decriminalization Consumption 52

CannaTech

OCTOBER 14, 2018

However, when Proposition 64 passed in 2016, effectively legalizing recreational marijuana use, an unfortunate side effect was the inability to differentiate industrial hemp from its psychoactive counterpart, cannabis. billion by 2022, according to New Frontier Data, a premier cannabis data analytics firm. In the U.S.

Hemp 53

Hemp Research and Development Agriculture Seed-To-Sale 53

Cannabis Law Report

JANUARY 20, 2022

Eleusis designed ELE-Psilo, a proprietary psilocybin-based drug candidate that is formulated for IV infusion and in development for the treatment of depression. Eleusis secured an Innovation Passport Designation for ELE-Psilo in adult treatment-resistant depression under the U.K. About Silver Spike Capital.

Therapy 52

Therapy Research and Development Business Access 52

Cannabis Law Report

SEPTEMBER 12, 2021

Steve Sisolak signed Assembly Bill 101, making Nevada the first state to legalize the use of cannabinoids as a veterinary treatment. 1, 2017, following a 2016 ballot measure. Dr. Dawn Boothe is a professor of veterinary physiology and pharmacology at Auburn University studying cannabis’s potential as a veterinary treatment.

Patients 105

Patients Pets Seed-To-Sale Cannabinoids 105

Cannabis Law Report

NOVEMBER 24, 2021

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. At the same time, the outlook on cannabis research data is largely positive. Legalisation occurred in Australia in 2016. 2016 ; Sznitman et al. Before 2016, Australian law considered cannabis an illegal drug.

Research and Development 52

Research and Development Medicine Access Media 52

The Cannigma

JUNE 29, 2021

These terms refer to the chemical composition of cannabis plants, which is one of the main factors that determine the type of high you’ll experience, or the effectiveness of your cannabis treatment. It’s also the most appropriate for medical conditions such as depression , epilepsy , and autism spectrum disorder.

Terpenes 138

Terpenes Research and Development Cannabinoids Concentrates 138

Cannabis Law Report

OCTOBER 26, 2019

The TGA does not evaluate any data relating to the trial. Data exclusivityThe TG Act provides a data exclusivity period of five years in relation to therapeutic goods containing a new active component (that is, an active substance that has not previously been a component of a product entered in the ARTG).

Clinical Trials 45

Clinical Trials Medicine Research and Development Compliance 45

Green Relief

MAY 13, 2018

It is the most commonly identified cause of epilepsy among adults. Treatment modalities for TBI are limited with few satisfactory pharmaceutical options available. Preliminary data suggests that a synergistic combination of CBD and hypothermia may produce the best results. million Americans annually. CBD for CTE. Terpenes.

THC 64

THC CBD Cannabinoids Research and Development 64

Green Relief

MAY 12, 2018

It is the most commonly identified cause of epilepsy among adults. Treatment modalities for TBI are limited with few satisfactory pharmaceutical options available. Preliminary data suggests that a synergistic combination of CBD and hypothermia may produce the best results. million Americans annually. CBD for CTE. Terpenes.

Research and Development 40

Research and Development Cannabinoids Therapy CBD 40

Cannabis Law Report

JULY 12, 2019

Ultimately, the cannabinoid system works by way of multiple molecules affecting multiple receptors at once – the entourage effect, and thus such singular approaches to treatment by way of the cannabinoid system are not effective. An Israeli study of cannabis versus epilepsy, however, used natural extracts with a ratio of 20:1 CBD:THC.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Cannabis Law Report

SEPTEMBER 12, 2019

That’s when Leon County Circuit Judge Charles Dodson ruled that Florida’s license cap violated the 2016 voter-approved initiative, which was a constitutional amendment. The ruling could potentially lift both the cap and the requirement that operators must be vertically integrated.

Seed-To-Sale 65

Seed-To-Sale Supply Chain Business Programs 65